Loading…
Drugs Made In America Acquisition II Corp. is projected to rise to $12.11 by 2027, a +20% move from its current price of $10.10. DMII is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $10.08 | $10.10 | $10.13 | +0.03% |
| Jul 14 | $10.07 | $10.11 | $10.14 | +0.07% |
| Jul 15 | $10.06 | $10.11 | $10.16 | +0.10% |
| Jul 16 | $10.06 | $10.11 | $10.17 | +0.14% |
| Jul 17 | $10.06 | $10.12 | $10.18 | +0.17% |
| Jul 18 | $10.06 | $10.12 | $10.19 | +0.21% |
| Jul 19 | $10.05 | $10.12 | $10.19 | +0.24% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $10.05 | $10.12 | $10.19 | +0.24% |
| Week 2 | $10.05 | $10.15 | $10.25 | +0.48% |
| Week 3 | $10.05 | $10.17 | $10.30 | +0.72% |
| Week 4 | $10.06 | $10.20 | $10.34 | +0.96% |
| Week 5 | $10.06 | $10.22 | $10.38 | +1.21% |
| Week 6 | $10.07 | $10.25 | $10.42 | +1.45% |
| Week 7 | $10.08 | $10.27 | $10.46 | +1.69% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Drugs Made In America Acquisition II Corp. (DMII) is a company categorized in Financial Services. It does not have significant operations and focuses on effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses.
DMII intends to source and evaluate companies focused on the pharmaceutical sector. The company was incorporated in 2024 and is based in New York, New York. The description places its current emphasis on pursuing strategic opportunities in the pharmaceutical space within a financial services framework.
The focus and classification reflect a transitional entity whose described goal is to pursue corporate combinations and related transactions rather than ongoing operating activities at this time.
DMII trades at $10.09 and has a market capitalization of $642.73M. It is ranked 2676 by market cap among listed assets.
Forecasts show an upward trajectory over the coming years, with 2026 averaging $10.09 (range $9.88 to $14.16) and continuing growth to 2050 averaging $76.02 (range $42.41 to $142.41). The long-term path implies sizable upside with higher average prices and substantial return potential by 2050.
Sentiment in the forecast shifts from Neutral in 2026–2027 to Bullish from 2028 onward, aligning with the rising price outlook and expanding target ranges.
A major floor 1.6% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.5% away) — a key level to hold.
Price is pressing into resistance (0.0% away) — a breakout level to watch.
A major ceiling 0.3% above — clearing it would confirm fresh momentum.
Key DMII support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of DMII market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $10.10 | Buy | $10.10 | Buy |
| MA 10 | $10.08 | Buy | $10.09 | Buy |
| MA 20 | $10.08 | Buy | $10.08 | Buy |
| MA 50 | $10.06 | Buy | $10.06 | Buy |
| MA 100 | $10.02 | Buy | $10.03 | Buy |
| MA 200 | — | Neutral | — | Neutral |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 60.46 | Neutral |
| Stoch RSI (14) | 72.69 | Neutral |
| CCI (20) | 85.71 | Neutral |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 0.00 | Buy |
| ROC (12) | 0.20 | Buy |
| Bollinger %B (20,2) | 0.77 | Neutral |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | 0.01 | Buy |
| Awesome (5,34) | 0.02 | Buy |
| Ultimate (7,14,28) | 79.87 | Sell |
| Momentum (10) | 0.03 | Buy |
| Aroon Osc (25) | 36.00 | Buy |
| Hull MA (9) | 10.11 | Sell |
| ADX (14) | 26.28 | Buy |
| ATR (14) | 0.01 | Info |
Technical picture is BULLISH. The RSI(14) is 70, indicating strong momentum near overbought territory.
The 50-day simple moving average (SMA50) is $10.04, with a nearby support at $10.01 and resistance at $10.10. The 30-day price range is $10.05 to $10.13, illustrating a tight trading band around the current level.
Annualized volatility is 1%, suggesting a relatively low volatility environment over the period.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $9.88 | $10.10 | $14.07 | 0% | Neutral | |
| $9.61 | $12.11 | $16.16 | +20% | Neutral | |
| $10.29 | $13.35 | $18.50 | +32% | Bullish | |
| $10.56 | $14.03 | $20.05 | +39% | Bullish | |
| $11.53 | $15.65 | $22.92 | +55% | Bullish | |
| $13.34 | $18.46 | $27.63 | +83% | Bullish | |
| $15.14 | $21.33 | $32.57 | +111% | Bullish | |
| $16.61 | $23.80 | $36.99 | +136% | Bullish | |
| $17.41 | $25.36 | $40.05 | +151% | Bullish | |
| $18.32 | $27.09 | $43.44 | +168% | Bullish | |
| $26.21 | $41.59 | $71.04 | +312% | Bullish | |
| $42.73 | $76.54 | $143.32 | +658% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $9.88 | $10.10 | $12.11 | +0.00% |
| August 2026 | $8.81 | $10.40 | $12.63 | +3.02% |
| September 2026 | $8.76 | $10.42 | $12.79 | +0.16% |
| October 2026 | $8.69 | $10.40 | $12.89 | -0.20% |
| November 2026 | $8.95 | $10.77 | $13.46 | +3.59% |
| December 2026 | $9.24 | $11.17 | $14.07 | +3.70% |
Click any year to see its month-by-month DMII forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect DMII to range from $9.88 to $14.07 through 2026. The $10.10 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The DMII price prediction for 2027 points to an average of $12.11 (low $9.61, high $16.16) — a potential gain of +20% on today's $10.10. A consolidation phase looks the most probable path here.
In 2028, DMII is projected to trade between $10.29 and $18.50, averaging $13.35 — a potential gain of +32% from today's $10.10. That is up +10% on the projected 2027 average. Momentum favours further upside here.
Drugs Made In America Acquisition II Corp.'s 2029 outlook centres on $14.03, within a $10.56 to $20.05 range. That is up +5% on the projected 2028 average. That marks a +39% change versus current levels. Buyers look set to stay in control over this stretch.
By 2030, DMII could reach as high as $22.92, with a base case around $15.65 and support toward $11.53 — roughly +55% from $10.10. Momentum favours further upside here.
Expect DMII to range from $13.34 to $27.63 through 2031. The $18.46 average target implies a +83% move from current prices. That is up +18% on the projected 2030 average. Buyers look set to stay in control over this stretch.
The DMII price prediction for 2032 points to an average of $21.33 (low $15.14, high $32.57) — a potential gain of +111% on today's $10.10. Momentum favours further upside here.
In 2033, DMII is projected to trade between $16.61 and $36.99, averaging $23.80 — a potential gain of +136% from today's $10.10. That is up +12% on the projected 2032 average. Buyers look set to stay in control over this stretch.
Drugs Made In America Acquisition II Corp.'s 2034 outlook centres on $25.36, within a $17.41 to $40.05 range. That is up +7% on the projected 2033 average. That marks a +151% change versus current levels. Momentum favours further upside here.
By 2035, DMII could reach as high as $43.44, with a base case around $27.09 and support toward $18.32 — roughly +168% from $10.10. Buyers look set to stay in control over this stretch.
Expect DMII to range from $26.21 to $71.04 through 2040. The $41.59 average target implies a +312% move from current prices. That is up +54% on the projected 2035 average. Momentum favours further upside here.
The DMII price prediction for 2050 points to an average of $76.54 (low $42.73, high $143.32) — a potential gain of +658% on today's $10.10. Buyers look set to stay in control over this stretch.
Investing $1,000 in DMII today (≈ 99.009901 DMII) could be worth
$7,577.9
+$6,577.9 (+658%) by 2050 · US Dollar
Based on the average projected DMII price of $76.54 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in DMIIwould be worth at today's price.
$1,000 invested in DMII on Dec 3, 2025 (≈ 101.214574 DMII) would be worth
$1,022.27
+$22.27 (+2.2%) today · 1.02× · US Dollar
Based on a DMII entry price of $9.88 vs. today's $10.1.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $10.09 | $1,000.99 | +0.1% |
| 1 month ago | $10.09 | $1,000.99 | +0.1% |
| 3 months ago | $9.99 | $1,011.01 | +1.1% |
| 6 months ago | $9.92 | $1,018.15 | +1.8% |
| All time ago | $9.88 | $1,022.27 | +2.2% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our DMII forecast.
Our base-case forecast reaches $20.00 around 2032.
Implied market cap at $20.00: $1.27B
The multi-year forecast shows a clear upside path. For 2030, the average price is projected to be $15.67 with a max of $22.97 and a min of $11.53, delivering an estimated ROI of 55.3% and a bullish sentiment.
By 2040, the average price is projected to be $41.96 with a max of $71.71 and a min of $26.43, delivering an estimated ROI of 315.9% and a bullish sentiment.
In 2050, the average price is projected to be $76.02 with a max of $142.41 and a min of $42.41, delivering an estimated ROI of 653.4% and a bullish sentiment. The forecast generally trends higher across years, with growing investor confidence reflected in rising average prices and ROI figures.
Tap a question to reveal the answer.
In 2030 the forecast shows an average price of $15.67, a min of $11.53, and a max of $22.97, with an ROI of 55.3% and bullish sentiment.
The forecast indicates upside with an average price rising over time and an ROI reaching 653.4% by 2050, supported by bullish sentiment in later years, though early years show neutral to mixed signals.
Yes. The 2029 max is $20.01 and the 2030 max is $22.97, with further upside in later years.
The current price is $10.09 and the market capitalization is $642.73M.
For 2040, the forecast shows an average price of $41.96, a min of $26.43, a max of $71.71, with an ROI of 315.9% and bullish sentiment.
Drugs Made In America Acquisition II Corp. Community Discussion
0Share your Drugs Made In America Acquisition II Corp. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.